MedTrace Logo

SpyGlass Direct Visualization System Clinical Registry in China

NCT02287194 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 197

Last updated 2018-07-31

No results posted yet for this study

Summary

To document indications for cholangioscopy and clinical utility of the SpyGlass Direct Visualization System in China when used per standard of practice.

Prospective, Post market, Multi-center, Non-randomized Study

Conditions

  • Biliary Tract Diseases

Interventions

DEVICE

SpyGlass

The SpyGlass Direct Visualization System is an integrated product platform that is designed to provide a direct intraluminal view of the biliary duct system and direct therapeutic devices.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Zhaoshen Li, Prof. · Changhai Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-28
Primary Completion
2016-04-30
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02287194 on ClinicalTrials.gov